Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Detection of Familial Pancreatic Neoplasms by Endoscopic Ultrasonography, MDCT, and MR Cholangiopancreatography

By HospiMedica International staff writers
Posted on 13 Aug 2008
Lives can be saved if high-grade dysplasia and early familial ductal adenocarcinoma can be detected in high-risk individuals before these lesions progress to advanced disease. More...
In a recent study, researchers evaluated different imaging modalities for preoperative detection of familial pancreatic neoplasms.

The investigators looked to characterize pancreatic neoplastic lesions detected by imaging tests in high-risk individuals; to compare the diagnostic yield and incremental benefit of endoscopic ultrasonography (EUS) over multidetector computed tomography (MDCT)/magnetic resonance cholangiopancreatography (MRCP); and to determine the incremental benefit of fine-needle aspiration (FNA) over EUS alone.

Data prospectively collected by investigators led by Marcia I. Canto, M.D., FASGE, an associate professor of medicine and oncology at Johns Hopkins University (Baltimore, MD, USA), from 1998-2007 from two screening studies and the center's clinical screening program were analyzed. High-risk individuals with Peutz-Jeghers syndrome or first-degree relatives from familial ductal adenocarcinoma kindreds with at least two affected, had MDCT or MRI/MRCP or both, and EUS. Radiologic and EUS features of each preoperatively detected lesion were compared with the pathologic findings. The diagnostic yield of each imaging modality was calculated on a per-lesion basis.

Of 165 patients who had EUS and CT/MRCP, 19 asymptomatic high-risk individuals underwent partial resection (15), partial followed by completion pancreatectomy (3), or total pancreatectomy (1) for 44 pancreatic lesions (size range 2.6-21 mm) detected by EUS, MDCT, or MRCP.

The researchers concluded that most pancreatic neoplasms detected by screening tests are small and low grade, but 6% of intraductal papillary mucinous neoplasms < 3 cm may contain high-grade dysplasia. EUS detects almost twice as many neoplastic lesions as CT/MRCP, regardless of size, and FNA adds little to EUS.

The study's findings were presented in May 2008, at the Digestive Disease Week (DDW) 2008, held in San Diego, CA, USA.

Related Links:
Johns Hopkins University


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.